Announcement
18 May 2021
In May 2021, the French government provided further financing to OSE Immunotherapeutics to develop a new COVID-19 vaccine candidate. The support was given under the France Relance framework.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
1 in force
Implementation date
18 May 2021
Revocation date:
No revocation date
State loan
In force
On 18 May 2021, the French government provided a EUR 10.7 (approx. USD 13.1 million) loan to OSE Immunotherapeutics for financing the next stages of the development of a COVID-19 vaccine candidate. Th...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.